Literature DB >> 30939124

Deficiency of Socs3 leads to brain-targeted EAE via enhanced neutrophil activation and ROS production.

Zhaoqi Yan1, Wei Yang1, Luke Parkitny1, Sara A Gibson2, Kevin S Lee1, Forrest Collins1, Jessy S Deshane3, Wayne Cheng4, Amy S Weinmann4, Hairong Wei1, Hongwei Qin1, Etty N Benveniste1.   

Abstract

Dysregulation of the JAK/STAT signaling pathway is associated with Multiple Sclerosis (MS) and its mouse model, Experimental Autoimmune Encephalomyelitis (EAE). Suppressors Of Cytokine Signaling (SOCS) negatively regulate the JAK/STAT pathway. We previously reported a severe, brain-targeted, atypical form of EAE in mice lacking Socs3 in myeloid cells (Socs3ΔLysM), which is associated with cerebellar neutrophil infiltration. There is emerging evidence that neutrophils are detrimental in the pathology of MS/EAE, however, their exact function is unclear. Here we demonstrate that neutrophils from the cerebellum of Socs3ΔLysM mice show a hyper-activated phenotype with excessive production of reactive oxygen species (ROS) at the peak of EAE. Neutralization of ROS in vivo delayed the onset and reduced severity of atypical EAE. Mechanistically, Socs3-deficient neutrophils exhibit enhanced STAT3 activation, a hyper-activated phenotype in response to G-CSF, and upon G-CSF priming, increased ROS production. Neutralization of G-CSF in vivo significantly reduced the incidence and severity of the atypical EAE phenotype. Overall, our work elucidates that hypersensitivity of G-CSF/STAT3 signaling in Socs3ΔLysM mice leads to atypical EAE by enhanced neutrophil activation and increased oxidative stress, which may explain the detrimental role of G-CSF in MS patients.

Entities:  

Keywords:  Autoimmunity; Inflammation; Multiple sclerosis; Neutrophils; Signal transduction

Year:  2019        PMID: 30939124      PMCID: PMC6538334          DOI: 10.1172/jci.insight.126520

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  100 in total

1.  G-CSF therapy of ongoing experimental allergic encephalomyelitis via chemokine- and cytokine-based immune deviation.

Authors:  Flora Zavala; Sébastien Abad; Sophie Ezine; Véronique Taupin; Annie Masson; Jean-François Bach
Journal:  J Immunol       Date:  2002-02-15       Impact factor: 5.422

2.  Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor.

Authors:  H Openshaw; O Stuve; J P Antel; R Nash; B T Lund; L P Weiner; A Kashyap; P McSweeney; S Forman
Journal:  Neurology       Date:  2000-06-13       Impact factor: 9.910

3.  STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils.

Authors:  Athanasia D Panopoulos; Ling Zhang; Jonathan W Snow; Daniel M Jones; Amber M Smith; Karim C El Kasmi; Fulu Liu; Mark A Goldsmith; Daniel C Link; Peter J Murray; Stephanie S Watowich
Journal:  Blood       Date:  2006-08-03       Impact factor: 22.113

4.  IFN-gamma determines distinct clinical outcomes in autoimmune encephalomyelitis.

Authors:  Allen K Wensky; Glaucia C Furtado; Maria Cecilia Garibaldi Marcondes; Shaohua Chen; Denise Manfra; Sergio A Lira; David Zagzag; Juan J Lafaille
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

5.  Involvement of SNAP-23 and syntaxin 6 in human neutrophil exocytosis.

Authors:  B Martín-Martín; S M Nabokina; J Blasi; P A Lazo; F Mollinedo
Journal:  Blood       Date:  2000-10-01       Impact factor: 22.113

6.  pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity.

Authors:  Giovanni Frisullo; Francesco Angelucci; Marcella Caggiula; Viviana Nociti; Raffaele Iorio; Agata Katia Patanella; Cristina Sancricca; Massimiliano Mirabella; Pietro Attilio Tonali; Anna Paola Batocchi
Journal:  J Neurosci Res       Date:  2006-10       Impact factor: 4.164

7.  SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis.

Authors:  Ben A Croker; Donald Metcalf; Lorraine Robb; Wei Wei; Sandra Mifsud; Ladina DiRago; Leonie A Cluse; Kate D Sutherland; Lynne Hartley; Emily Williams; Jian-Guo Zhang; Douglas J Hilton; Nicos A Nicola; Warren S Alexander; Andrew W Roberts
Journal:  Immunity       Date:  2004-02       Impact factor: 31.745

8.  SOCS3 negatively regulates IL-6 signaling in vivo.

Authors:  Ben A Croker; Danielle L Krebs; Jian-Guo Zhang; Sam Wormald; Tracy A Willson; Edouard G Stanley; Lorraine Robb; Christopher J Greenhalgh; Irmgard Förster; Björn E Clausen; Nicos A Nicola; Donald Metcalf; Douglas J Hilton; Andrew W Roberts; Warren S Alexander
Journal:  Nat Immunol       Date:  2003-05-18       Impact factor: 25.606

9.  Nox2-derived reactive oxygen species mediate neurovascular dysregulation in the aging mouse brain.

Authors:  Laibaik Park; Josef Anrather; Helene Girouard; Ping Zhou; Costantino Iadecola
Journal:  J Cereb Blood Flow Metab       Date:  2007-04-11       Impact factor: 6.200

10.  SOCS3 is a physiological negative regulator for granulopoiesis and granulocyte colony-stimulating factor receptor signaling.

Authors:  Akiko Kimura; Ichiko Kinjyo; Yumiko Matsumura; Hiroyuki Mori; Ryuichi Mashima; Mine Harada; Kenneth R Chien; Hideo Yasukawa; Akihiko Yoshimura
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

View more
  11 in total

1.  Characterization and regulation of osteoclast precursors following chronic Porphyromonas gingivalis infection.

Authors:  Yanfang Zhao; Zhaofei Li; Lingkai Su; Andre Ballesteros-Tato; Jannet Katz; Suzanne M Michalek; Xu Feng; Ping Zhang
Journal:  J Leukoc Biol       Date:  2020-08-17       Impact factor: 4.962

Review 2.  Effects of dietary restriction on gut microbiota and CNS autoimmunity.

Authors:  Claudia Cantoni; Yair Dorsett; Luigi Fontana; Yanjiao Zhou; Laura Piccio
Journal:  Clin Immunol       Date:  2020-08-18       Impact factor: 3.969

Review 3.  Hypoxia-inducible factor-1 drives divergent immunomodulatory functions in the pathogenesis of autoimmune diseases.

Authors:  S M Touhidul Islam; Jeseong Won; Mushfiquddin Khan; Mark D Mannie; Inderjit Singh
Journal:  Immunology       Date:  2021-04-27       Impact factor: 7.215

4.  NAD+ attenuates experimental autoimmune encephalomyelitis through induction of CD11b+ gr-1+ myeloid-derived suppressor cells.

Authors:  Jin-Li Wang; Bin Li; Guo-Jun Tan; Xiao-Li Gai; Jun-Na Xing; Jue-Qiong Wang; Mo-Yuan Quan; Ning Zhang; Li Guo
Journal:  Biosci Rep       Date:  2020-04-30       Impact factor: 3.840

5.  Independent and inter-dependent immunoregulatory effects of NCF1 and NOS2 in experimental autoimmune encephalomyelitis.

Authors:  Jianghong Zhong; Anthony C Y Yau; Rikard Holmdahl
Journal:  J Neuroinflammation       Date:  2020-04-11       Impact factor: 8.322

6.  Neutrophil-selective deletion of Cxcr2 protects against CNS neurodegeneration in a mouse model of multiple sclerosis.

Authors:  Yee Ming Khaw; Claire Cunningham; Abigail Tierney; Mayandi Sivaguru; Makoto Inoue
Journal:  J Neuroinflammation       Date:  2020-02-04       Impact factor: 8.322

7.  Anti-inflammatory, antioxidant and renoprotective effects of SOCS1 mimetic peptide in the BTBR ob/ob mouse model of type 2 diabetes.

Authors:  Jesús Egido; Carmen Gomez-Guerrero; Sergio Mezzano; Lucas Opazo-Ríos; Yenniffer Sanchez Matus; Raúl R Rodrigues-Díez; Daniel Carpio; Alejandra Droguett
Journal:  BMJ Open Diabetes Res Care       Date:  2020-09

Review 8.  Molecular Biomarkers in Multiple Sclerosis and Its Related Disorders: A Critical Review.

Authors:  Maryam Gul; Amirhossein Azari Jafari; Muffaqam Shah; Seyyedmohammadsadeq Mirmoeeni; Safee Ullah Haider; Sadia Moinuddin; Ammar Chaudhry
Journal:  Int J Mol Sci       Date:  2020-08-21       Impact factor: 5.923

9.  Dysregulation of the Adaptive Immune System in Patients With Early-Stage Parkinson Disease.

Authors:  Zhaoqi Yan; Wei Yang; Hairong Wei; Marissa N Dean; David G Standaert; Gary R Cutter; Etty N Benveniste; Hongwei Qin
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-07-22

10.  STAT3 signaling in myeloid cells promotes pathogenic myelin-specific T cell differentiation and autoimmune demyelination.

Authors:  Hsueh Chung Lu; Sunja Kim; Andrew J Steelman; Kevin Tracy; Beiyan Zhou; Danielle Michaud; Andrew E Hillhouse; Kranti Konganti; Jianrong Li
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.